CN Stock MarketDetailed Quotes

688276 Changchun Bcht Biotechnology

Watchlist
  • 27.89
  • +0.10+0.36%
Market Closed Dec 12 15:00 CST
11.54BMarket Cap27.83P/E (TTM)

Changchun Bcht Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Changchun Bcht Biotechnology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 237.000M--
--2024/Q4-- / 680.000M--
--2024/Q3407.611M / 800.000M--
Aug 16, 20242024/Q2348.113M / 507.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 237.000M--
--2024/Q4-- / 680.000M--
--2024/Q3407.611M / 800.000M--
Aug 16, 20242024/Q2348.113M / 507.000M--
--------

Unlock Free Earnings Estimates

Changchun Bcht Biotechnology Earnings Reports

  • Changchun Baike Biotechnology Co., Ltd. report for the third quarter of 2024

    Oct 25 12:00 ET

  • Changchun Baike Biological Technology Co., Ltd.'s 2024 bi-annual report.

    Aug 15 12:00 ET

  • Changchun Baike Biotechnology Co., Ltd.'s summary of the first half-year report for 2024.

    Aug 15 12:00 ET

  • Changchun Baike Biotechnology Co., Ltd. report for the first quarter of 2024

    Apr 19 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 12, 2024

    Strong Buy

    • Strong Buy

      81.25%

    • Buy

      12.50%

    • Hold

      6.25%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Biological Vaccine
    Biological Vaccine
    Intraday+1.24%
    Transferring Securities of Securities
    Transferring Securities of Securities
    Intraday+1.01%
    Finance and Securities Lending
    Finance and Securities Lending
    Intraday+1.01%